XML 36 R20.htm IDEA: XBRL DOCUMENT
v3.24.1

Note 14 - Parent Company Financial Statements (Unaudited) | 12 Months Ended
--- | ---
Dec. 31, 2023
Notes to Financial Statements |
Condensed Financial Information of Parent Company Only Disclosure [Text Block] | 14. Parent Company Financial Statements (Unaudited) We conduct substantially all of our operations through subsidiaries and are dependent on cash distributions, dividends and other intercompany transfers of funds from our operations. Our subsidiaries have not made significant distributions to us and may not have funds available for dividends or distributions in the future. The ability of our subsidiaries to transfer funds to us will be dependent upon their respective abilities to achieve sufficient cash flows after satisfying their respective cash requirements, including subsidiary level debt service on their respective credit agreements. The following is a summary of the Parent Company Financial statements. Aemetis, Inc. (Parent Company) Balance Sheets As of December 31, 2023 and 2022
|  | 2023 |  |  | 2022 |
Assets |  |  |  |  |  |  |  |
Current assets |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 1,454 |  |  | $ | 286 |
Receivables due from subsidiaries |  |  | 110,083 |  |  |  | 98,780 |
Prepaid expenses |  |  | 437 |  |  |  | 611 |
Other current assets |  |  | 12 |  |  |  | 7 |
Total current assets |  |  | 111,986 |  |  |  | 99,684 |
Investment in Aemetis Property Keyes, Inc. |  |  | 1,556 |  |  |  | 1,274 |
Investment in Aemetis International, Inc. |  |  | 12,059 |  |  |  | 6,659 |
Investment in Aemetis Advanced Products Riverbank, Inc. |  |  | 638 |  |  |  | 173 |
Investment in AE Advanced Products Keyes , Inc. |  |  | 246 |  |  |  | - |
Total investments in Subsidiaries, net of advances |  |  | 14,499 |  |  |  | 8,106 |
Property, plant and equipment, net |  |  | 149 |  |  |  | 135 |
Other assets |  |  | 2,096 |  |  |  | 2,377 |
Total Assets |  | $ | 128,730 |  |  | $ | 110,302 |
Liabilities & stockholders' deficit |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |
Accounts payable |  | $ | 3,633 |  |  | $ | 2,934 |
Mandatorily redeemable Series B convertible preferred |  |  | 4,521 |  |  |  | 4,082 |
Other current liabilities |  |  | 5,031 |  |  |  | 4,269 |
Total current liabilities |  |  | 13,185 |  |  |  | 11,285 |
Long term liabilities: |  |  |  |  |  |  |  |
Operating lease liability |  |  | 1,716 |  |  |  | 2,047 |
Subsidiary obligation in excess of investment |  |  |  |  |  |  |  |
Investment in AE Advanced Fuels, Inc. |  |  | 220,571 |  |  |  | 177,856 |
Investment in Aemetis Americas, Inc |  |  | 202 |  |  |  | 205 |
Investment in Aemetis Biofuels, Inc. |  |  | 2,721 |  |  |  | 2,738 |
Investment in Aemetis Technologies, Inc. |  |  | 4,868 |  |  |  | 4,716 |
Investment in AE Advanced Products Keyes , Inc. |  |  | - |  |  |  | 270 |
Investment in Aemetis Health Products, Inc. |  |  | 2,084 |  |  |  | 2,076 |
Investment in Goodland Advanced Fuels, Inc. |  |  | 22,982 |  |  |  | 16,869 |
Investment in Aemetis Biogas LLC |  |  | 70,471 |  |  |  | 91,292 |
Investment in Aemetis Carbon Capture Inc |  |  | 5,895 |  |  |  | 2,323 |
Investment in Aemetis Properties Riverbank, Inc. |  |  | 1,012 |  |  |  | 479 |
Total subsidiary obligation in excess of investment |  |  | 330,806 |  |  |  | 298,824 |
Total long term liabilities |  |  | 332,522 |  |  |  | 300,871 |
Stockholders' deficit |  |  |  |  |  |  |  |
Series B Preferred convertible stock |  |  | - |  |  |  | 1 |
Common stock |  |  | 41 |  |  |  | 36 |
Additional paid-in capital |  |  | 264,058 |  |  |  | 232,546 |
Accumulated deficit |  |  | (475,405 | ) |  |  | (428,985 | )
Accumulated other comprehensive loss |  |  | (5,671 | ) |  |  | (5,452 | )
Total stockholders' deficit |  |  | (216,977 | ) |  |  | (201,854 | )
Total liabilities & stockholders' deficit |  | $ | 128,730 |  |  | $ | 110,302 |
Aemetis, Inc. (Parent Company) Statements of Operations and Comprehensive Loss For the Years Ended December 31, 2023 and 2022
|  | 2023 |  |  | 2022 |
Equity in subsidiary losses |  | $ | (25,370 | ) |  | $ | (91,561 | )
Selling, general and administrative expenses |  |  | 19,218 |  |  |  | 15,203 |
Operating loss |  |  | (44,588 | ) |  |  | (106,764 | )
Other (income) expense |  |  |  |  |  |  |  |
Interest expense |  |  | 1,073 |  |  |  | 806 |
Debt related fees and amortization expense |  |  | 781 |  |  |  | 1,581 |
Other income |  |  | (30 | ) |  |  | (1,400 | )
Loss before income taxes |  |  | (46,412 | ) |  |  | (107,751 | )
Income tax expense |  |  | 8 |  |  |  | 7 |
Net loss |  |  | (46,420 | ) |  |  | (107,758 | )
Other comprehensive loss |  |  |  |  |  |  |  |
Foreign currency translation adjustment |  |  | (219 | ) |  |  | (1,102 | )
Comprehensive loss |  | $ | (46,639 | ) |  | $ | (108,860 | )
Aemetis, Inc. (Parent Company) Statements of Cash Flows For the years ended December 31, 2023 and 2022
|  | 2023 |  |  | 2022 |
Operating activities: |  |  |  |  |  |  |  |
Net loss |  |  | (46,420 | ) |  |  | (107,758 | )
Adjustments to reconcile net loss to net cash used in operating activities: |  |  |  |  |  |  |  |
Stock-based compensation |  |  | 7,660 |  |  |  | 6,410 |
Depreciation |  |  | 51 |  |  |  | 29 |
Debt related fees and amortization expense |  |  | 782 |  |  |  | 1,776 |
Subsidiary portion of net losses |  |  | 25,370 |  |  |  | 91,561 |
Gain on litigation |  |  | - |  |  |  | (1,400 | )
Warrants issued for working capital agreement |  |  | 409 |  |  |  | - |
Changes in assets and liabilities: |  |  |  |  |  |  |  |
Prepaid expenses |  |  | (608 | ) |  |  | 111 |
Accounts payable |  |  | 699 |  |  |  | (90 | )
Accrued interest expense |  |  | 785 |  |  |  | 778 |
Other liabilities |  |  | 85 |  |  |  | (4,625 | )
Other assets |  |  | 276 |  |  |  | 207 |
Net cash used in operating activities |  |  | (10,911 | ) |  |  | (13,001 | )
Investing activities: |  |  |  |  |  |  |  |
Capital expenditures |  |  | (65 | ) |  |  | (128 | )
Subsidiary advances, net |  |  | (9,707 | ) |  |  | 1,222 |
Net cash provided by (used in) investing activities |  |  | (9,772 | ) |  |  | 1,094 |
Financing activities: |  |  |  |  |  |  |  |
Proceeds from the exercise of stock options |  |  | 133 |  |  |  | 206 |
Proceeds from issuance of common stock in equity offering |  |  | 21,718 |  |  |  | 11,987 |
Net cash provided by financing activities |  |  | 21,851 |  |  |  | 12,193 |
Net increase in cash, cash equivalents, and restricted cash |  |  | 1,168 |  |  |  | 286 |
Cash, cash equivalents and restricted cash at beginning of period |  |  | 286 |  |  |  | - |
Cash, cash equivalents, and restricted cash at end of period |  | $ | 1,454 |  |  | $ | 286 |
Supplemental disclosures of cash flow information, cash paid: |  |  |  |  |  |  |  |
Income taxes paid |  |  | 7 |  |  |  | 7 |
Supplemental disclosures of cash flow information, non-cash transactions: |  |  |  |  |  |  |  |
Fair value of warrants issued to subordinated debt holders |  |  | 1,278 |  |  |  | 1,939 |
Fair value of stock issued to a related party for guarantee fees |  |  | - |  |  |  | 2,012 |
Fair value of warrants issued for capital expenditures |  |  | 318 |  |  |  | - |
Fair value of warrants issued to lender for debt issuance costs |  |  | - |  |  |  | 3,158 |
Fair value of stock issued to lender |  |  | - |  |  |  | 1,335 |

X
- Definition The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.5-04(Schedule I)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480922/205-10-S99-6 Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481231/810-10-45-11 + Details
Name: | us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration